February 2009 Volume 5, Issue 2
Volume 5, Issue 2 | February 2009
February 2009
In this Issue
Research & Development
Pfizer buys Wyeth for $68B
Will cut 800 R&D jobs as company seeks reinvention in face of patent expirationsTown meets gown in J&J-Vandy deal
Janssen Pharmaceutica and Vanderbilt University forge industry-academia research partnershipHealing the wounded
OmegaGenesis, Mayo Clinic to develop nanomaterials for angiogenesis applicationsIs nanotechnology safe?
U.S. lawmakers address need for more risk research, oversightPPD acquires Merck’s 130,000 square-foot vaccine lab
PPD Inc. recently entered a strategic collaboration with Merck & Co. Inc. whereby it acquired the latter’s vaccine testing lab in Wayne, Pa.Roche lines up at Synta’s CRACM gate
Billion-dollar alliance to produce oral agents for arthritis, inflammatory diseasesGlobal News
Out-of-pocket expense
Lilly pays $1.4 billion to end Zyprexa probe, with cash earmarked for settlementOf (bio)similar interests
Teva and Lonza seek to capture a large chunk of the emerging biosimilars marketPlaying hard to get
EXACT Sciences rejects $41 million acquisition offer, and Sequenom refuses to give chaseWarding off MS
Apitope and Merck Serono to advance MS vaccineOut of failure, opportunity
The Medicines Company acquires Targanta for $42MGenomics & Proteomics
Running interferon
Bristol-Myers Squibb, ZymoGenetics PEG-Interferon lambda deal could be worth $1 billionBreathing new life into pipeline
Alnylam and Cubist enter into partnership to develop RNAi therapeutics for respiratory syncytial virus infectionThey’re locked and loaded
RNA deal with Wyeth could mean as much as $847 million to Santaris even before royaltiesCardio candidates
Mutant gene puts South Asians at much higher risk of heart diseaseNCI planning to look far and (genome) wide
Agency plans to award up to $96 million for multicenter genome-wide association studiesAutomation & Instrumentation
Culture for growth
Hamilton, GCS collaboration yields high-density cell culture product‘Simple but elegant’ system
UT Southwestern Medical Center to use WaferGen’s SmartChip system to identify gene expression biomarkers involved in wound healingTest tube trials
VistaGen, Capsant merge stem cells, cell culture and measurement tools for new screening platformA sign of the times?
LabAutomation 2009 doesn’t skip a beat with strong year-opening eventBioTrove, Cisbio enter screening services distribution deal
Companies will combine Cisbio’s HTRF with BioTrove’s RapidFire mass spec platformEditor's Focus
Does anyone know what 2009 holds?
Heading for LabAutomation 2009 in Palm Springs, I was sure I would get a pulse on what folks in the industry felt about the financial crisis. But if I went with plenty of questions, I probably came back with a whole bunch more.Patent News
Bayer sues Abbott over Humira; Abbott thanks them with their own lawsuit
Last month, Abbott Laboratories was sued by Bayer AG’s HealthCare unit, alleging that Abbott's best-selling drug Humira infringes on a Bayer patent. In one new twist, Abbott has sued Bayer AG’s HealthCare unit, claiming the Bayer patent is invalid, not infringed or unenforceable.Informatics
Image is everything
PerkinElmer and IDBS aim to ease high-content screening analysis burdens with Columbus-ActivityBase integrationThe release of FireFly
Prosolio and Indigo BioSystems create data conversion software for mass spec usersDelving downstream
Ariadne integrates Pathway Studio with Illumina’s GenomeStudio softwareFDA e-data review in next Phase Forward
FDA extends use of Phase Forward’s WebSDM software in submission and review of electronic CDISC format data
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Thermo Scientific™ Centrifuges with GreenCool Technology
Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
The crucial role of sample preparation in biotherapy manufacturing
Discover how better sample preparation can unlock improved assay accuracy and analytical results.
Discovering deeper insights into malaria research
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
